Detection of epithelial carcinoma cells in the blood of patients with gynaecological malignancies

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 1093-1097

  Sehouli, Jalid ^a   Könsgen, Dominique ^a   Nimpsch, Robert ^a   Oskay, Gülten ^a   Stengel, Dirk ^b   Oertel, Joachim ^a   Lichtenegger, Werner ^a   Mustea, Alexandru ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Dept of Traumatolgy/Emergency Hosp ^*  (Germany)

Author keywords

Cytokeratin; Epithelial cells; Gynaecological cancer

Indexed keywords

BLOOD SAMPLING; CANCER CYTODIAGNOSIS; CANCER GRADING; CARCINOMA CELL; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; EPITHELIUM; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; EPITHELIAL CELLS; FEMALE; GENITAL DISEASES, FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS;

EID: 0038205868     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Parker SL, Tong T, Bolden S and Wingo PA:Cancer statistics. CA Cancer J Clin 46(1): 3-4, 1996.
2. Illiger HJ: Der monoklonale Antikörper17-1A. Internist 38: 1001-06, 1997.
3. Diel IJ: Metaanalyse zur prognostischen bedeutung des tumorzellnachweises im knochenmark oder "Auf der suche nach dem unabhängigen prognosefaktor". Strahlenther Onkl 175: 44-6, 1999.
4. Oruzio D, Hempel D et al.: Knochenmarkmikrometastasen epithelialer tumoren, nachweis und klinische bedeutung. Onkologe 3: 66-72, 1997.
5. Sharp JG: Micrometastases and transplantation. J Hematother 5:519-24, 1996.
6. Janni W, Gastroph S, Hepp F, Kentenich C, Rjosk D, Schindlbeck C, Dimpfl T, Sommer H and Braun S: Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma. Cancer 15;88(10): 2252-9, 2000.
7. Zhong XY, Kaul S, Diel I, Eichler A and Bastert G: Sensitivität und spezifittit der immunzytologie für den tumorzellnachweis im knochenmark bei patientinnen mit mammakarzinom. Tumordiagn.u. Ther 20: 39-44, 1999.
8. Pantel K, Braun S, Passlick S and Schlimok G: Minimal residual epithelial cancer: diagnostic approaches and prognostic relevance. Prog Histo-/Cytochem 30: 1-60, 1996.
9. Pantel K, Schlimok G, Angstwurm M et al: Methodological analysis of immunocytochemical screening for disseminated epithelial tumour cells in bone marrow. J Hematother 3: 165-173, 1994.
10. Slovin SF and Scher HI: Detectable tumor cells in the blood and bone marrow; smoke or fire?, Cancer 1(83), Nr. 3; 394-398, 1998.
11. Funke I et al: Metaanalysis of studies on bone marrow micrometastases. An independent prognostic impact remains to be substantiated. J Clin Oncol 16: 557-66, 1998.
12. Hepp F, Kentenich CRM, Janni W and Braun S: Clinical value of screening (CK)positive bone marrow micrometastases in stage I-II cervical cancer. Eur J Cancer 35(4): 230, 1999.
13. th ASCO Annual Meeting.
14. Harbeck N et al: Tumor cell detection in the bone marrow of breast cancer patients at primary therapy:results of a 3-year median follow-up. Br J Cancer 69: 566-71, 1994.
15. Mansi JL et al: The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol 7(4): 445-449, 1998.
16. Untch M, Nestle-Krämling, Konecny G et al.: Prognostic value of tumor cells in bone marrow in breast cancer. Gynakol Geburtshilfliche Rundsch 33 (Suppl) 1: 308-10 (German), 1993.
17. Thorban S, Rosenberg R, Busch R and Roder RJ: Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer 83(1): 35-9, 2000.
18. Weitz J, Kienle P, Magener A et al.: Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Clin Cancer Res 5(7): 1830-6, 1999.
19. Berger U, Bettelheim R, Mansi JL et al.: The relationsihip between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol 90: 1-6, 1998.
20. Smith BM, Slade MJ, English J, Graham H et al: Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction an immunocytochemical techniques. J Clin Oncol 18(7): 1432-9, 2000.
21. Zhong XY, Kaul S, Eichler A, and Bastert G: Low specificity of MUC1 as a marker to detect epithelial cancer dissemination in human bone marrow and blood. Clin Lab 44: 971-978, 1998.
22. Marth C, Trope C, Hofeldt H et-al.: Carcinoma cells in bone marrow and peripheral blood of ovarian cancer patients. The Norwegian Radium Hospital Oslo, Norway; (Poster)-Onkolog. Kongress, Berlin-Charité, 1998.
23. th ASCO Annual Meeting.
24. Kruger W, Krzizanowski C, Holweg M et al.: RT/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients. J Cancer Res Clin Oncol 122(11): 679-86, 1996.
25. Schlimok G, Funke I, Holzmann B et al.: Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti 17-1A monoclonal antibodies. Proc Natl Acad Sci USA 84: 8672-8676, 1987.
26. Schlimok G, Funke I, Pantel K et al.: Micrometastatic tumor cells in bone marrow of patients with gastric cancer: methodological aspects of detection and orognostic significance. Eur J Cancer 27: 1461-1465, 1991.
27. Krismann M, Todt B, Schroder J, Gareis D, Muller KM, Seeber S and Schutte J: Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13(11): 2769-75, 1995.
28. Mailer P, Weckermann D, Riethmüller G and Schlimok G: Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridisation. Cancer Genet Cytogenet 88: 8-16, 1996
29. Engel H, Kleespies C et al.: Detection of circulating tumour cells in patients with breast or ovarian cancer by molecular cytogenetics. Br J Cancer 81: 1165-73, 1999.